2012
DOI: 10.1097/iae.0b013e318255d38a
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and Therapeutic Challenges

Abstract: An 11-year-old African American girl presented to the ophthalmology clinic with a 2-month history of progressive vision loss with no associated discomfort. Her medical history for the past 8 months is notable for fatigue, decreased appetite, a 10-pound weight loss, left-sided temporal headaches, shortness of breath, dyspnea on exertion, intermittent abdominal pain, diarrhea, muscle aches, night sweats, and subjective fevers. The patient's recent history is also notable for rhinorrhea and mild coughing producti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…The diagnosis of isolated occlusive retinal vasculitis was made after clinically excluding infective and specific systemic and ocular inflammatory conditions, as supported by negative laboratory results . Systemic treatment was instigated as vision became threatened; however, immunosuppressive therapy, preferably steroid‐sparing to minimise the numerous adverse effects secondary to prolonged high‐dose steroid use, should not be started until an infective aetiology has been satisfactorily ruled out to avoid exacerbation of infection . Additionally, the patient must be closely monitored for relapse with titration of maintenance therapy in conjunction with the rheumatologist.…”
Section: Discussionmentioning
confidence: 99%
“…The diagnosis of isolated occlusive retinal vasculitis was made after clinically excluding infective and specific systemic and ocular inflammatory conditions, as supported by negative laboratory results . Systemic treatment was instigated as vision became threatened; however, immunosuppressive therapy, preferably steroid‐sparing to minimise the numerous adverse effects secondary to prolonged high‐dose steroid use, should not be started until an infective aetiology has been satisfactorily ruled out to avoid exacerbation of infection . Additionally, the patient must be closely monitored for relapse with titration of maintenance therapy in conjunction with the rheumatologist.…”
Section: Discussionmentioning
confidence: 99%